The Prognostic Value of hsCRP in CVD/CKD Among East Asian Population: A Scoping Review

Xiangyi Kong1, Ling Du2, Wenyan Liu2

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

JACC. Asia
|October 9, 2025
PubMed

Insights

Elevated high-sensitivity C-reactive protein (hsCRP) is linked to increased cardiovascular disease (CVD) and chronic kidney disease (CKD) risk in East Asians. Higher hsCRP levels also predict major adverse cardiac events (MACE) in these patient groups.

Area of Science:

  • Biomedical Science
  • Cardiology
  • Nephrology

Background:

  • Systemic inflammation, indicated by high-sensitivity C-reactive protein (hsCRP), impacts cardiovascular disease (CVD) and chronic kidney disease (CKD).
  • The prognostic significance of hsCRP in East Asian populations for CVD and CKD requires further clarification.

Purpose of the Study:

  • To conduct a scoping review evaluating the prognostic value of hsCRP for CVD and CKD in East Asian populations.
  • To synthesize existing evidence on the association between hsCRP levels and the risk and outcomes of CVD and CKD.

Main Methods:

  • Systematic electronic searches were performed in PubMed, Embase, and the Cochrane Library.
  • Included were English-language studies published before January 9, 2024, focusing on hsCRP, CVD/CKD, and East Asian populations.
  • Protocol pre-registration number: INPLASY202490133.

Main Results:

  • A significant majority of studies reported higher hsCRP levels in CVD and CKD patients compared to controls.
  • Elevated hsCRP was associated with an increased risk of CVD and CKD incidence.
  • Higher hsCRP levels were consistently linked to major adverse cardiac events (MACE) in patients with atherosclerotic CVD, heart failure, and CKD.

Conclusions:

  • Elevated hsCRP levels are associated with an increased risk of CVD/CKD and MACE in East Asian populations.
  • Further large-scale prospective studies and meta-analyses are recommended to validate these findings.
  • hsCRP shows potential as a prognostic biomarker for CVD and CKD in this demographic.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
389
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
538
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
339
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
189
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
260
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
560